查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1621535

局部止血剂市场：按产品、配方、应用和最终用途 - 全球预测 2025-2030

Topical Hemostat Market by Product, Formulation, Application, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，局部止血剂市场价值为21.2亿美元，预计到2024年将达到22.6亿美元，复合年增长率为6.80%，预计到2030年将达到33.6亿美元。

局部止血剂透过促进身体的自然凝血过程，对于控制外科手术过程中的出血至关重要。局部止血剂用于医院、诊所和门诊手术中心等多个领域，是减少术中和术后出血的重要工具。它在减少手术併发症和改善患者治疗效果方面的有效性凸显了其需求。主要应用在心血管手术、重组手术、整形外科和创伤手术等外科手术。该市场受到手术发生率上升、出血性疾病盛行率增加以及止血产品进步等因素的推动。为了满足各种外科手术的需求，有很大机会开发先进的止血材料，例如更易于使用且更有效的缓释性和生物分解性製剂。此外，由于医疗保健支出的增加和基础设施的发展，新兴市场的潜力尚未开发。然而，市场成长受到诸如严格的监管要求、潜在的产品召回以及与先进止血设备相关的高成本挑战的阻碍。为了抓住市场机会，公司应专注于产品开发创新，重点是更快的止血反应和最小的副作用。此外，与医疗机构的联合研发和数位行销策略可能会提高市场渗透率。市场竞争激烈，并受到技术进步的推动，需要持续投资研发才能保持领先。进入利基市场并探索组合产品，例如将止血剂和抗生素结合以降低感染风险的产品，可以提供明显的优势。总体而言，专注于研究具有成本效益、永续和多功能的止血剂有可能显着促进市场成长并满足关键的临床需求。

主要市场统计
基准年[2023] 21.2亿美元
预测年份 [2024] 22.6亿美元
预测年份 [2030] 33.6亿美元
复合年增长率（%） 6.80%

市场动态：快速发展的局部止血剂市场的关键市场洞察

供需的动态交互作用正在改变局部止血剂市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 由于人口老化和慢性病流行导致手术数量增加
    • 医疗监管机构的有利产品核可
  • 市场限制因素
    • 与局部止血产品相关的高成本
  • 市场机会
    • 持续研发推出新型外用止血剂
    • 整合奈米技术开发更高效的局部止血材料
  • 市场挑战
    • 与使用局部止血剂相关的操作限制和感染风险

波特的五力：驾驭局部止血剂市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外用止血剂市场的外部影响

外部宏观环境因素在塑造外用止血剂市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解外用止血剂市场的竞争状况

对局部止血剂市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵局部止血剂市场供应商的绩效评估

FPNV定位矩阵是评估外用止血剂市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘外用止血剂市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，局部止血剂市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于人口老化和慢性病的蔓延，手术数量不断增加。
      • 医疗监管机构的有利产品核可
    • 抑制因素
      • 与局部止血产品相关的高成本
    • 机会
      • 正在进行研发以推出新型外用止血剂
      • 整合奈米技术开发更有效率的局部止血剂
    • 任务
      • 与使用局部止血剂相关的操作限制和感染风险
  • 市场区隔分析
    • 产品：由于减少感染等额外好处，复合局部止血剂的采用正在迅速增加。
    • 配方：基质和凝胶止血剂的使用正在扩大，因为它们能够贴合不规则的伤口表面。
    • 应用：局部止血剂在心血管手术的重要用途
    • 最终用途：医院局部止血剂使用的演变
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 局部止血剂市场：副产品

  • 胶原蛋白局部止血剂
  • 复方局部止血剂
  • 明胶局部止血剂
  • 氧化再生纤维素系局部止血剂
  • 基于凝血酶的局部止血剂

第七章 处方外用止血剂市场

  • 基质和凝胶止血剂
  • 粉末止血剂
  • 片材和止血垫片
  • 海绵止血剂

第八章局部止血剂市场：依应用分类

  • 心血管外科
  • 一般外科
  • 肝臟和脾臟撕裂
  • 整形外科
  • 重组手术

第九章外用止血剂市场：依最终用途分类

  • 医院
  • 疗养院
  • 手术中心

第十章美洲局部止血剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区局部止血剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲局部止血剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Ethicon 推出 ETHIZIA 止血密封贴片，临床证明可止血
    • Medcura 的 LifeGel 可吸收手术止血材料获得突破性器械称号
    • Hemostasis 完成对 Feargon Medical Technologies 的收购
  • 战略分析和建议

公司名单

  • Aegis Lifesciences Private Limited
  • Axio Biosolutions Pvt Ltd
  • B.Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • BioCer Entwicklungs-GmbH
  • Bristol-Myers Squibb Company
  • Dilon Technologies Inc
  • GELITA MEDICAL GmbH
  • Hemostasis, LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Marine Polymer Technologies, Inc.
  • Medline Industries, LP
  • Medtrade Products Ltd
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd
  • Pfizer Inc.
  • Southmedic Inc.
  • Stryker Corporation
  • SYMATESE SAS
  • Takeda Pharmaceutical Company Limited
  • Teleflex Incorporated
  • Zeria Pharmaceutical Co., Ltd.
Product Code: MRR-031AB52F47EB

The Topical Hemostat Market was valued at USD 2.12 billion in 2023, expected to reach USD 2.26 billion in 2024, and is projected to grow at a CAGR of 6.80%, to USD 3.36 billion by 2030.

Topical Hemostats are pivotal in managing bleeding during surgical procedures by accelerating the body's natural clotting process. The scope of topical hemostats spans various sectors including hospitals, clinics, and ambulatory surgical centers, where they serve as critical tools for minimizing intraoperative and postoperative bleeding. Their necessity is underscored by their effectiveness in reducing surgical complications and improving patient outcomes. Key applications involve surgical procedures across cardiovascular, reconstructive, orthopedic, and trauma surgeries. The market is propelled by factors such as the rising incidence of surgeries, increasing prevalence of bleeding disorders, and advancements in hemostatic products. There is a significant opportunity in developing advanced hemostat formulations that combine ease of use with enhanced efficacy, such as time-release formulations and biodegradable options, to cater to diverse surgical needs. Furthermore, emerging markets present untapped potential due to increasing healthcare expenditure and infrastructure development. However, market growth is challenged by factors such as stringent regulatory requirements, potential product recalls, and high costs associated with advanced hemostatic devices. To capture market opportunities, businesses should focus on innovation in product development emphasizing faster hemostatic response and minimal adverse reactions. Additionally, exploring collaborative ventures with healthcare institutions for R&D and leveraging digital marketing strategies could enhance market penetration. The nature of this market is highly competitive and driven by technological advancements, necessitating continuous investment in R&D to stay ahead. Breaking into niche markets and exploring combination products, like those pairing hemostats with antibiotics to reduce infection risks, could offer a distinct advantage. Overall, focused research on cost-effective, sustainable, and multi-functional hemostatic agents could significantly boost market growth and address key clinical demands.

KEY MARKET STATISTICS
Base Year [2023] USD 2.12 billion
Estimated Year [2024] USD 2.26 billion
Forecast Year [2030] USD 3.36 billion
CAGR (%) 6.80%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Topical Hemostat Market

The Topical Hemostat Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising numbers of surgeries due to an aging population and prevalence of chronic diseases
    • Favorable product approval by medical regulators
  • Market Restraints
    • High costs associated with topical hemostat products
  • Market Opportunities
    • Ongoing R&D for the introduction of novel topical hemostat
    • Integration of nanotechnology to create more efficient topical hemostats
  • Market Challenges
    • Operational limitations and risk of infection associated with the use of topical hemostats

Porter's Five Forces: A Strategic Tool for Navigating the Topical Hemostat Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Topical Hemostat Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Topical Hemostat Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Topical Hemostat Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Topical Hemostat Market

A detailed market share analysis in the Topical Hemostat Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Topical Hemostat Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Topical Hemostat Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Topical Hemostat Market

A strategic analysis of the Topical Hemostat Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Topical Hemostat Market, highlighting leading vendors and their innovative profiles. These include Aegis Lifesciences Private Limited, Axio Biosolutions Pvt Ltd, B.Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Betatech Medical, BioCer Entwicklungs-GmbH, Bristol-Myers Squibb Company, Dilon Technologies Inc, GELITA MEDICAL GmbH, Hemostasis, LLC, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Marine Polymer Technologies, Inc., Medline Industries, LP, Medtrade Products Ltd, Medtronic PLC, Meril Life Sciences Pvt. Ltd, Pfizer Inc., Southmedic Inc., Stryker Corporation, SYMATESE SAS, Takeda Pharmaceutical Company Limited, Teleflex Incorporated, and Zeria Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Topical Hemostat Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Collagen-Based Topical Hemostats, Combination Topical Hemostats, Gelatin-Based Topical Hemostats, Oxidized Regenerated Cellulose-based Topical Hemostats, and Thrombin-Based Topical Hemostats.
  • Based on Formulation, market is studied across Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats, and Sponge Hemostats.
  • Based on Application, market is studied across Cardiovascular Surgery, General Surgery, Liver & Spleen Lacerations, Orthopedic Surgery, and Reconstructive Surgery.
  • Based on End-Use, market is studied across Hospitals, Nursing Homes, and Surgical Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising numbers of surgeries due to an aging population and prevalence of chronic diseases
      • 5.1.1.2. Favorable product approval by medical regulators
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with topical hemostat products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D for the introduction of novel topical hemostat
      • 5.1.3.2. Integration of nanotechnology to create more efficient topical hemostats
    • 5.1.4. Challenges
      • 5.1.4.1. Operational limitations and risk of infection associated with the use of topical hemostats
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Burgeoning adoption of combination topical hemostats owing to the additional benefits such as infection reduction
    • 5.2.2. Formulation: Proliferating utilization of matrix and gel hemostats owing to their ability to conform to irregular wound surfaces
    • 5.2.3. Application: Significant usage of topical hemostats in cardiovascular surgery
    • 5.2.4. End-Use: Evolving utilization of topical hemostats in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Topical Hemostat Market, by Product

  • 6.1. Introduction
  • 6.2. Collagen-Based Topical Hemostats
  • 6.3. Combination Topical Hemostats
  • 6.4. Gelatin-Based Topical Hemostats
  • 6.5. Oxidized Regenerated Cellulose-based Topical Hemostats
  • 6.6. Thrombin-Based Topical Hemostats

7. Topical Hemostat Market, by Formulation

  • 7.1. Introduction
  • 7.2. Matrix & Gel Hemostats
  • 7.3. Powder Hemostats
  • 7.4. Sheet & Pad Hemostats
  • 7.5. Sponge Hemostats

8. Topical Hemostat Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgery
  • 8.3. General Surgery
  • 8.4. Liver & Spleen Lacerations
  • 8.5. Orthopedic Surgery
  • 8.6. Reconstructive Surgery

9. Topical Hemostat Market, by End-Use

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Nursing Homes
  • 9.4. Surgical Centers

10. Americas Topical Hemostat Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Topical Hemostat Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Topical Hemostat Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Ethicon Introduces ETHIZIA Hemostatic Sealing Patch, Clinically Proven to Stop Disruptive Bleeding
    • 13.3.2. Medcura Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
    • 13.3.3. Hemostasis Closes Acquisition of Fiagon Medical Technologies
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aegis Lifesciences Private Limited
  • 2. Axio Biosolutions Pvt Ltd
  • 3. B.Braun Melsungen AG
  • 4. Baxter International, Inc.
  • 5. Becton, Dickinson and Company
  • 6. Betatech Medical
  • 7. BioCer Entwicklungs-GmbH
  • 8. Bristol-Myers Squibb Company
  • 9. Dilon Technologies Inc
  • 10. GELITA MEDICAL GmbH
  • 11. Hemostasis, LLC
  • 12. Integra LifeSciences Corporation
  • 13. Johnson & Johnson Services, Inc.
  • 14. Marine Polymer Technologies, Inc.
  • 15. Medline Industries, LP
  • 16. Medtrade Products Ltd
  • 17. Medtronic PLC
  • 18. Meril Life Sciences Pvt. Ltd
  • 19. Pfizer Inc.
  • 20. Southmedic Inc.
  • 21. Stryker Corporation
  • 22. SYMATESE SAS
  • 23. Takeda Pharmaceutical Company Limited
  • 24. Teleflex Incorporated
  • 25. Zeria Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. TOPICAL HEMOSTAT MARKET RESEARCH PROCESS
  • FIGURE 2. TOPICAL HEMOSTAT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TOPICAL HEMOSTAT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TOPICAL HEMOSTAT MARKET DYNAMICS
  • TABLE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY LIVER & SPLEEN LACERATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 196. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2023